The FDA announced participation in the COVID-19 Diagnostics Evidence Accelerator
On Jun. 18, 2020, the FDA announced participation in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project…
Tonix Pharma and Southern Research announced expansion of COVID-19 vaccine collaboration
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
Montefiore and Einstein lead major NYC Health Centers in publishing largest body of data in US about pregnant women and COVID
On Jun. 18, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine, in collaboration with…
Tomatoï¾’s hidden mutations revealed in study of 100 varieties
On Jun. 17, 2020, HHMI investigators reported they had identified long-concealed hidden mutations within the genomes of 100…
NIH-funded study linked endometriosis to DNA changes
On Jun. 17, 2020, DNA from uterine cells of women with endometriosis has different chemical modifications, compared to…
Oxford University and Bvlgari announced collaboration to fight COVID-19 and future pandemics
On Jun. 17, 2020, Bvlgari, the Italian luxury brand, announced plans to support research into COVID-19 and vaccine…
CureVac received regulatory approval from German and Belgian authorities to initiate phase 1 clinical trial of its SARS-CoV-2 vaccine candidate
On Jun. 17, 2020, CureVac announced that the German Health Authority Paul-Ehrlich-Institute and the Belgian Federal Agency for…
Innovation Pharma’s Brilacidin inhibited SARS-CoV-2 by 97 percent in a human lung cell line
On Jun. 17, 2020, Innovation Pharma reported receiving data from ongoing laboratory testing being conducted at a U.S….
Aclaris Therapeutics supported investigator-initiated clinical trial of ATI-450 for cytokine release syndrome in hospitalized COVID-19 patients
On Jun. 17, 2020, Aclaris Therapeutics announced that the FDA had allowed an investigational new drug application to…
The FDA revoked Emergency Use Authorization for Chembio antibody test
On Jun. 16, 2020, the FDA revoked the emergency use authorization (EUA) of the Chembio Diagnostic System DPP…
All of Us Research Program launched COVID-19 research initiatives
On Jun. 16, 2020, the All of Us Research Program, part of the National Institutes of Health, announced…
Low-cost dexamethasone reduced death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
On Jun. 16, 2020, the University of Oxford reported that overall dexamethasone reduced the 28-day mortality rate by…
Pneumonia vaccine price dropped dramatically for lower-income countries thanks to the Gavi pneumococcal Advance Market Commitment
On Jun. 16, 2020, lower-income countries across the world have access life-saving pneumococcal conjugate vaccines, which protect against…
NanoString announced new products to advance COVID-19 disease research
On Jun. 16, 2020, NanoString Technologies announced the availability of new solutions to study the immune response in…
The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
On Jun. 15, 2020, the FDA revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and…
NIH launched analytics platform to harness nationwide COVID-19 patient data to speed treatments
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…
The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD
On Jun. 15, 2020, the FDA permitted marketing of the first game-based digital therapeutic device to improve attention…
German Federal Government invested 300 million Euros in CureVac
On Jun. 15, 2020, the German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp,…
Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
Super-potent human antibodies protect against COVID-19 in animal tests
On Jun. 15, 2020, a team led by Scripps Research discovered antibodies in the blood of recovered COVID-19…
Adamis Pharma announced license to commercialize Tempol, a novel investigational anti-inflammatory and antioxidant drug for treatment of respiratory diseases
On Jun. 15, 2020, Adamis Pharma announced a license to commercialize Tempol, a novel patented investigational drug for…
Lilly begans phase 3 clinical trial with baricitinib for hospitalized COVID-19 patients
On Jun. 15, 2020, Eli Lilly announced that the first patient has been enrolled in a Phase 3…
Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
Immunic announced first patients dosed in its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
Cleveland Clinic researchers developed first model to predict likelihood of testing positive for COVID-19 and outcomes from the disease
On Jun. 15, 2020, Cleveland Clinic researchers announced they had developed the worldï¾’s first risk prediction model for…
McKesson to distribute COVID-19 vaccines in support of Operation Warp Speed
On Jun. 14, 2020, McKesson announced that it had expanded its existing partnership with the Centers for Disease…
AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityï¾’s vaccine at no profit
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeï¾’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
A cluster of COVID-19 in Beijing, People’s Republic of China was reported
On Jun. 13, 2020, officials from the WHO National Health Commission and Beijing Health Commission announced preliminary investigations…
Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyï¾’s…
FDA approved HPV vaccine Gardasil as throat cancer prevention
On Jun. 12, 2020, the FDA announced it had approved an expanded indication for Merck’s GARDASIL9 for the…